An Interview with Michael M. Gottesman, M.D.
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2009/06/01
-
Indian UGC (journal)
-
Refrences1
-
Vicki Glaser
Cite
Glaser, Vicki. “An Interview With Michael M. Gottesman, M.D”. ASSAY and Drug Development Technologies, vol. 7, no. 3, 2009, pp. 213-8, https://doi.org/10.1089/adt.2009.9991.
Glaser, V. (2009). An Interview with Michael M. Gottesman, M.D. ASSAY and Drug Development Technologies, 7(3), 213-218. https://doi.org/10.1089/adt.2009.9991
Glaser V. An Interview with Michael M. Gottesman, M.D. ASSAY and Drug Development Technologies. 2009;7(3):213-8.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Peptide therapeutics: current status and future directions
- Exploiting the enhanced permeability and retention effect for tumor targeting
- Natural products in drug discovery
- A new and rapid colorimetric determination of acetylcholinesterase activity
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
A "Silent" Polymorphism in the
MDR
1 Gene Changes Substrate Specificity | Science |
| 1,758 | 2007 |